PKM2 binds to tyrosine-phosphorylated β-catenin in the nucleus and contributes to β-catenin-mediated transactivation of cyclin D and c-Myc, thereby promoting both cell proliferation and tumor progression (Figure 3). This evidence concerns the gene PKM and neoplasm.